Vericel Statistics
NASDAQ: VCELHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
40.74+0.69 (+1.72%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Vericel by the numbers
Vericel has a market capitalization of $2.09 billion based on 51.21M shares outstanding. Its trailing P/E ratio is 86.7, and its forward P/E is 48.2. The stock trades 2.9% below its 50-day average and 6.3% above its 200-day average.
Average daily trading volume is 503.13K shares, or about $20.5 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
VCEL valuation vs. peer median
| Metric | VCEL | Peer median | Difference |
|---|---|---|---|
| Market cap | $2.09B | $2.12B | -1% |
| Forward P/E | 48.2 | 18.2 | +165% |
| Avg. volume | 503.13K | 2.27M | -78% |
Peer median across 8 companies: ALVO, BCRX, VIR, NVAX, ADMA, RXRX, MESO, BEAM.
Valuation
- Market cap
- $2.09B
- P/E (TTM)
- 86.68
- Forward P/E
- 48.16
- EPS (TTM)
- $0.47
- Shares outstanding
- 51.21M
Price and trading
- Previous close
- 40.05
- Open
- 39.67
- Day range
- 39.60 – 41.40
- 52-week range
- 28.95 – 49.32
- 52-week change
- +23.04%
- Beta
- —
- Volume
- 647.00K
- Average volume
- 503.13K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 2.09B
- Pe
- 86.68
- Forward Pe
- 48.16
- Eps
- 0.47
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 49.32
- Week52 Low
- 28.95
- Avg Volume
- 503.13K
- Shares Outstanding
- 51.21M
- Ma50
- 41.95
- Ma200
- 38.32
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -17.40%
- Pct From52w Low
- 40.73%